Denali Therapeutics
DNLI
#3453
Rank
NZ$7.49 B
Marketcap
NZ$47.21
Share price
1.95%
Change (1 day)
97.63%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: NZ$7.49 Billion

As of July 2026 Denali Therapeutics has a market cap of NZ$7.49 Billion. This makes Denali Therapeutics the world's 3453th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$7.49 B64.73%
2025NZ$4.54 B-13.51%
2024NZ$5.25 B12.15%
2023NZ$4.68 B-21.17%
2022NZ$5.94 B-25.4%
2021NZ$7.97 B-42.72%
2020NZ$13.92 B459.51%
2019NZ$2.48 B-14.67%
2018NZ$2.91 B50.49%
2017NZ$1.93 B

End of Day market cap according to different sources

On Jul 8th, 2026 the market cap of Denali Therapeutics was reported to be:

NZ$7.34 Billion
by Nasdaq info icon info icon
NZ$7.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Organovo
ONVO
NZ$6.37 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ$0.65 B-91.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$2.68 B-64.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
NZ$3.47 B-53.63% Jersey